(S)-6-(TRIFLUOROMETHYL)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-AMINE HCL, 95.0%, 250mg

2-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid, 95.0%, 25g

Methyl 4-Nitro-1H-pyrazole-3-carboxylate, 95.0%, 1g

GC capillary column ROTI®Cap-5 MS, 60 m, 0.25 mm, 0.50 µm, 1 Piece(s)

(S)-METHYL 3-AMINO-2,3-DIHYDRO-1H-INDENE-5-CARBOXYLATE HYDROCHLORIDE, 95.0%, 250mg

N-(4-(N-(Thiazol-2-yl)sulfamoyl)phenyl)acetamide, 95%, 100mg

N,N-DIETHYL-3-NITROPYRIDIN-2-AMINE, 97.0%, 5g

2-(2-((tert-Butoxycarbonyl)amino)-N-methylacetamido)acetic acid, 97%, 100mg

2,6-Bis((S)-4-cyclohexyl-4,5-dihydrooxazol-2-yl)pyridine, 98% 99%ee, 1g

N,N-Dibenzyl-3-methylaniline, 98.0%, 250mg

(R)-tert-Butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate hydrochloride, 95.0%, 5g

8-Hydroxyquinoline-5-carbaldehyde, 95.0%, 5g

SECNIDAZOLE, 97.0%, 500g